Works matching IS 25098020 AND DT 2018 AND VI 2 AND IP 1

Results: 63
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Patient-reported outcomes for patients with metastatic castration-resistant prostate cancer receiving docetaxel and Atrasentan versus docetaxel and placebo in a randomized phase III clinical trial (SWOG S0421).

    Published in:
    Journal of Patient-Reported Outcomes, 2018, v. 2, n. 1, p. N.PAG, doi. 10.1186/s41687-018-0054-5
    By:
    • Unger, Joseph M.;
    • Griffin, Katherine;
    • Donaldson, Gary W.;
    • Baranowski, Karen M.;
    • Good, Margorie J.;
    • Reburiano, Eunicia;
    • Hussain, Maha;
    • Monk, Paul J.;
    • Van Veldhuizen, Peter J.;
    • Carducci, Michael A.;
    • Higano, Celestia S.;
    • Lara, Primo N.;
    • Tangen, Catherine M.;
    • Quinn, David I.;
    • Wade, James L.;
    • III;
    • Vogelzang, Nicholas J.;
    • Thompson, Ian M.;
    • Jr;
    • Moinpour, Carol M.
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    Development of the Weight-Related Sign and Symptom Measure.

    Published in:
    Journal of Patient-Reported Outcomes, 2018, v. 2, n. 1, p. N.PAG, doi. 10.1186/s41687-018-0042-9
    By:
    • Brod, Meryl;
    • Højbjerre, Lise;
    • Pfeiffer, Kathryn M.;
    • Sayner, Robyn;
    • Meincke, Henrik H.;
    • Patrick, Donald L.
    Publication type:
    Article
    46
    47
    48
    49
    50